Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Aliment Pharmacol Ther ; 45(2): 332-344, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27862096

RESUMO

BACKGROUND: Several recent studies have shown a strong association between non-alcoholic steatohepatitis (NASH) and chronic kidney disease. AIM: To examine the relationship between changes in liver histology and renal function in patients with NASH. METHODS: The present analysis represents a post hoc analysis of a recently published trial that included 261 patients with NASH who were treated with lifestyle modifications during 52 weeks. Kidney function was evaluated through Chronic Kidney Disease Epidemiology Collaboration estimated glomerular filtration rates (eGFR, mL/min/1.73 m2 ) overtime. We explored correlations between the kidney function and improvement in histological outcomes at 52 weeks. RESULTS: Interestingly, a one-stage reduction in fibrosis (r = 0.20, P < 0.01) and resolution of NASH (r = 0.17, P < 0.01) were significantly correlated with an improvement in the kidney function. The eGFR values significantly increased in patients with fibrosis improvement (+7.6 ± 6.5 mL/min/1.73 m2 ), compared to those without fibrosis improvement (-1.98 ± 6.4 mL/min/1.73 m2 ) (P < 0.01) at end of treatment (EOT). Likewise, NASH resolution was associated with an increase in eGFR compared with patients without NASH resolution (2.32 ± 7.8 mL/min/1.73 m2 vs. -1.04 ± 5.9 mL/min/1.73 m2 , P = 0.04) at EOT. After controlling for the confounders, the association between fibrosis improvement, NASH resolution and eGFR change remained significant (P < 0.05 for both). CONCLUSIONS: Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in NASH. As new drugs for NASH emerge, studies should address whether improvement in histology in response to pharmacotherapies yield the same improvement in kidney function as weight loss.


Assuntos
Rim/fisiologia , Estilo de Vida , Fígado/patologia , Hepatopatia Gordurosa não Alcoólica , Adulto , Feminino , Taxa de Filtração Glomerular , Humanos , Cirrose Hepática/patologia , Cirrose Hepática/fisiopatologia , Masculino , Pessoa de Meia-Idade , Hepatopatia Gordurosa não Alcoólica/patologia , Hepatopatia Gordurosa não Alcoólica/fisiopatologia
2.
Rev Gastroenterol Peru ; 21(3): 234-8, 2001.
Artigo em Espanhol | MEDLINE | ID: mdl-11818984

RESUMO

Fascioliasis is a cosmopolitan parasitic disease. The development of some diagnostic imaging methods such as ultrasonography (US) and endoscopic retrograde cholangio-pancreatography (ERCP) have provided the opportunity of detecting the presence of the parasite in the gall-bladder and in the extra-hepatic biliary tract. Four cases of fascioliasis in the biliary tract are shown, in which the ultrasonographic findings suggested a diagnosis of fascioliasis which was later confirmed by biliary drainage and/or stool culture. When there is no clinical evidence of parasitism, ultrasonography may help to assume the presence of the parasite. The ERCP is useful to confirm the location of the trematode in the extra-hepatic biliary tract. Biliary tract fascioliasis may present as a cholestatic syndrome.


Assuntos
Doenças dos Ductos Biliares/diagnóstico por imagem , Fasciolíase/diagnóstico por imagem , Adulto , Doenças dos Ductos Biliares/parasitologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Radiografia , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA